1. Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2. (4th July 2021) Authors: Puig, Luis; Wu, Jashin J.; Gooderham, Melinda J.; You, Yin; Shen, Yaung-Kaung; Randazzo, Bruce; Kerdel, Francisco Journal: Journal of dermatological treatment Issue: Volume 32:Number 5(2021) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2). Issue 11 (20th November 2016) Authors: Kavanaugh, Arthur; Puig, Lluis; Gottlieb, Alice B; Ritchlin, Christopher; You, Yin; Li, Shu; Song, Michael; Randazzo, Bruce; Rahman, Proton; McInnes, Iain B Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 11(2016) Page Start: 1984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2). Issue 11 (20th April 2016) Authors: Kavanaugh, Arthur; Puig, Lluis; Gottlieb, Alice B; Ritchlin, Christopher; You, Yin; Li, Shu; Song, Michael; Randazzo, Bruce; Rahman, Proton; McInnes, Iain B Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 11(2016) Page Start: 1984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study. (19th May 2022) Authors: Blauvelt, Andrew; Armstrong, April W.; Langley, Richard G.; Gebauer, Kurt; Thaçi, Diamant; Bagel, Jerry; Guenther, Lyn C.; Paul, Carle; Randazzo, Bruce; Flavin, Susan; Hsu, Ming-Chun; You, Yin; Reich, Kristian Journal: Journal of dermatological treatment Issue: Volume 33:Number 4(2022) Page Start: 2317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis. Issue 1 (10th October 2020) Authors: Zhou, Wangda; Hu, Chuanpu; Zhu, Yaowei; Randazzo, Bruce; Song, Michael; Sharma, Amarnath; Xu, Zhenhua; Zhou, Honghui Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 1(2021) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Issue 10201 (7th September 2019) Authors: Reich, Kristian; Armstrong, April W; Langley, Richard G; Flavin, Susan; Randazzo, Bruce; Li, Shu; Hsu, Ming-Chun; Branigan, Patrick; Blauvelt, Andrew Journal: Lancet Issue: Volume 394:Issue 10201(2019) Page Start: 831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P279 Guselkumab was more effective than secukinumab in patients with plaque psoriasis and the subset of patients with self-reported PsA in the randomised, double-blind, head-to-head comparison study ECLIPSE over 1 year. (20th April 2020) Authors: Merola, Joseph F; Li, Shu; Hsu, Ming-Chun; Karyekar, Chetan; Gorecki, Patricia C; Flavin, Susan; Randazzo, Bruce; Coates, Laura C Journal: Rheumatology Issue: Volume 59(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Population Pharmacokinetic Modeling of Guselkumab, a Human IgG1λ Monoclonal Antibody Targeting IL‐23, in Patients with Moderate to Severe Plaque Psoriasis. (17th January 2018) Authors: Yao, Zhenling; Hu, Chuanpu; Zhu, Yaowei; Xu, Zhenhua; Randazzo, Bruce; Wasfi, Yasmine; Chen, Yang; Sharma, Amarnath; Zhou, Honghui Journal: Journal of clinical pharmacology Issue: Volume 58:Number 5(2018) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0390 GUSELKUMAB WAS MORE EFFECTIVE THAN SECUKINUMAB IN PATIENTS WITH PLAQUE PSORIASIS AND THE SUBSET OF PATIENTS WITH SELF-REPORTED PSORIATIC ARTHRITIS IN THE RANDOMIZED, DOUBLE-BLIND, HEAD-TO-HEAD COMPARISON STUDY ECLIPSE OVER 1 YEAR. (June 2019) Authors: Merola, Joseph F.; Shu, LI; Hsu, Ming-Chun; Karyekar, Chetan; Flavin, Susan; Randazzo, Bruce; Coates, Laura C. Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗